Cancer Prevention News

Annual mammography beginning at age 40 or 41 years led to a reduction in breast cancer mortality while adding little to the burden of overdiagnosis, according to results of a randomized study in the U.K. published in The Lancet Oncology.

Mailed stool blood tests and follow-up phone calls are examples of effective strategies that increased colorectal cancer screening among African Americans, according to findings of a systematic review.

New model estimates demonstrate the long-term benefits of prostate cancer screening and “suggest that the balance of benefits and harms of screening may be more favorable than is generally appreciated,” experts wrote in The New England Journal of Medicine.

Acid-producing diets and past smoking history appeared independently and jointly associated with increased risk for mortality among a cohort of breast cancer survivors, according to study results published in Journal of Clinical Medicine.

Smoking modestly increased the risk for severe disease in hospitalized patients with COVID-19, particularly among younger patients without diabetes, according to a systematic review and meta-analysis.

Cancer survivors often overestimate the quality of their diets, reporting a higher-than-actual intake of fruits, vegetables and whole grains, according to study results published in European Journal of Clinical Nutrition.

Health care providers should begin offering routine HPV vaccination to children as young as age 9 years in order to increase rates of on-time administration, according to an updated American Cancer Society guideline.

The FDA expanded the indication of HPV 9-valent vaccine, recombinant to include prevention of oropharyngeal and other head and neck cancers caused by HPV types 16, 18, 31, 33, 45, 52 and 58, according to a manufacturer-issued press release.

Female physicians were more likely than male physicians to adhere to guidelines for pap smears, breast cancer screening and colon cancer screening, according to research that was scheduled to be presented at the ACP Internal Medicine Meeting.

The generalizability of the National Lung Screening Trial to community health settings was confirmed in a recent analysis, researchers said.